When PAX3-FOXO1 in primary tumor-derived cell lines was knocked out by CRISPR/CAS9, cell oncogenicity disappeared and these cell lines were differentiated following doxycycline withdrawal. This evidence concerns the gene PAX3 and neoplasm.